Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 16-0836536 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The treatment and cure of Hemophilia and other related blood disorders.
Principal Officer
Thomas Wilmarth
Total Revenue
$28.7M
FY2024
Total Expenses
$21.5M
FY2024
Net Assets
$32.7M
Program Ratio
96.9%
expenses on programs
Employees
10
Volunteers
14
Board Members
7
Voting
7
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.